TruTrace Technologies Closes Second Tranche of Private Placement

VANCOUVER, Sept. 13, 2019 /CNW/ – TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) (“TruTrace” or the “Company“) today announced that it has closed a second tranche (the “Second Tranche“) of a non-brokered private placement financing (the “Financing“).  The Second Tranche consisted of 840,950 units (each, a “Unit“) of the Company at a price of $0.25 per Unit for gross proceeds of $210,237.50. Each Unit consists of one common share and one non-transferable common share purchase warrant (each, a “Warrant“). Each Warrant entitles the holder to purchase one additional common share at a price of $0.30 per common share for a period of three (3) years from the closing of the Financing. To date, the Company has raised gross proceeds of $720,237.50 from the first tranche of the Financing and the Second Tranche.  The Company expects to close a third tranche of the Financing in a timely manner.

The Company issued 26,400 Shares and 26,400 Warrants to certain finders in connection with the closing of the Second Tranche.

The Company intends to use the funds received from the Second Tranche for general working capital.

All securities issued in the Second Tranche are subject to a statutory hold period expiring January 14, 2020.

About TruTrace Technologies:

TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. TruTrace’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. TruTrace’s technology is proprietary, immutable and cryptographically secure, thereby establishing an accurate and permanent account for cannabis strains from ownership to market.

Disclaimer for Forward-Looking Information

This news release contains forward-looking information that involves various risks and uncertainties regarding future events. Such forward-looking information can include without limitation statements based on current expectations involving a number of risks and uncertainties and are not guarantees of future performance of the Company, such as statements that the Company expects to close a third tranche of the Financing in a timely manner and the intended use of the funds received from the Second Tranche. There are numerous risks and uncertainties that could cause actual results and the Company’s plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; or (ii) the inability of the Company to close a third tranche of the Financing in a timely manner at all or on the terms announced. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

SOURCE TruTrace Technologies Inc.

For further information: TruTrace Technologies Inc.: Robert Galarza, Chief Executive Officer and Director; Media Relations: Corey Herscu, RNMKR Agency, 416-300-3030; Investor Inquiries: Swapan Kakumanu, Chief Financial Officer, 844-656-3629, swapan@trutrace.co

By OCN Media News

OnlyCannabisNews scours the web and brings you the latest and most important cannabis related news across a variety of categories. OnlyCannabisNews focuses on reporting and promoting the stories of people and organizations in the world of cannabis.

Last Updated September 13, 2019

..
..
Related Stories
Charlotte’s Web Launches Pet Chew for Dogs with Sensitive Skin

Charlotte’s Web Launches Pet Chew for Dogs with Sensitive Skin

Charlotte's Web™ Skin Health & Allergy Support Chews are chicken flavored and come in 30-count ($19.99 SRP) and 60-count ($34.99 SRP) sizes and are non-GMO and grain-free. Like all Charlotte's Web products, all pet SKUs are tested 20+ times from seed to shelf for...

Aurora Announces Manufacturing Agreement with The Valens Company

Aurora Announces Manufacturing Agreement with The Valens Company

New Seasonal Offerings Slated for November Release  EDMONTON, AB, Oct. 28, 2021 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced a manufacturing...

OCN Exclusive content
Shantal Arroyo: Clinique La Croix Verte

Shantal Arroyo: Clinique La Croix Verte

Who: Shantal Arroyo Title: Co-founder Organization: Clinique La Croix Verte Facebook Page Corporate SitePour lire cet article en français, veuillez suivre ce lien.Introduction to Shantal Arroyo Shantal Arroyo is the founder of Clinique La Croix Verte, a medical...

Shantal Arroyo: Clinique La Croix Verte (français)

Shantal Arroyo: Clinique La Croix Verte (français)

Qui: Shantal Arroyo Titre: Co-fondatrice Organization: Clinique La Croix Verte Page Facebook Site CorporatifTo read this article in English, please follow this link.Présentation de Shantal Arroyo   Shantal Arroyo est la fondatrice de la Clinique La Croix Verte,...

James Williams: Cannabis Manufacturer’s Guild

James Williams: Cannabis Manufacturer’s Guild

Who: James Williams Title: Co-founder Company: Cannabis Manufacturer's Guild Company LinkedIn Profile Company WebsiteIntroduction to James Williams OnlyCannabisNews was given the opportunity to interview James Williams of the Cannabis Manufacturer's Guild. James...